Covered recipient · General Payments record
CARLOS F VALLEJO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2020
$5,014.59
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.23 | 10 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | $121.09 | 1 |
| Allergan Inc. | $30.88 | 2 |
| Lilly USA, LLC | $28.00 | 2 |
| Radius Health, Inc. | $21.76 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.22 | 1 |
| Janssen Pharmaceuticals, Inc | $19.49 | 1 |
| Amgen Inc. | $17.38 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan, Inc. | $14.38 | 02/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723496909 | CMS |
| Allergan, Inc. | $16.50 | 03/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723496911 | CMS |
| Amgen Inc. | $17.38 | 04/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | 740950079 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.22 | 04/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 720425605 | CMS |
| Janssen Pharmaceuticals, Inc | $19.49 | 03/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | 719068615 | CMS |
| Lilly USA, LLC | $13.87 | 02/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728360779 | CMS |
| Lilly USA, LLC | $14.13 | 06/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728371147 | CMS |
| Radius Health, Inc. | $21.76 | 01/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 746293249 | CMS |
| Sunovion Pharmaceuticals Inc. | $121.09 | 01/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 748388019 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.41 | 06/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 749486271 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.